Janssen Research and Development, LLC, has entered into an agreement with Yale School of Medicine’s Open Data Access (YODA) Project to extend its commitment to sharing clinical trials data to enhance public health and advance science and medicine. Under the agreement, YODA will serve as an independent body to review requests from investigators and physicians seeking access to anonymised clinical trials data from Janssen and make final decisions on data sharing. This is the first time any company has collaborated with a completely independent third party to review and make decisions regarding every request for clinical data.
The agreement was announced today by Johnson & Johnson, the parent company of Janssen. In addition to sharing data from Janssen’s pharmaceutical product clinical trials through the agreement with YODA, Johnson & Johnson is also committed to sharing data from clinical trials of its medical device and consumer products.
Please read the press release from Johnson & Johnson here.
Media contact in Europe, Middle East & Africa:
Stefan Gijssels
Vice President Communication & Public Affairs Janssen EMEA
[email protected]
+32 473 71 04 25